BamSEC and AlphaSense Join Forces
Learn More

BioCryst Pharmaceuticals Inc.

NASDAQ: BCRX    
Share price (1/2/26): $7.50    
Market cap (1/2/26): $1.581 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 23 pages Amended and Restated By-Laws of Biocryst Pharmaceuticals, Inc. Effective January 16, 2024
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Amendment to the Third Restated Certificate of Incorporation of Biocryst Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Elimination of the Series B Junior Participating Preferred Stock of Biocryst Pharmaceuticals, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.1
from 425 2 pages First Amendment to Amended and Restated By-Laws of Biocryst Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages First Amendment to Amended and Restated By-Laws of Biocryst Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Increase of Authorized Number of Shares of Series B Junior Participating Preferred Stock of Biocryst Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Third Restated Certificate of Incorporation of Biocryst Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 20 pages Amended and Restated By-Laws of Biocryst Pharmaceuticals, Inc. Effective 10/29/08
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Increase of Authorized Number of Shares of Series B Junior Participating Preferred Stock of Biocryst Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 14 pages Amended and Restated By-Laws of Biocryst Pharmaceuticals, Inc. Effective 11/6/07 5
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Third Restated Certificate of Incorporation of Biocryst Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 11 pages Third Restated Certificate of Incorporation of Biocryst Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Certificate of Designation Establishing the Voting Powers, Designations, Preferences, Limitations, Restrictions, and Relative Rights of Series B Junior Participating Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 16 pages By-Laws of Biocryst Pharmaceuticals, Inc. Updated 12/15/05
12/34/56
EX-3.2
from 10-Q 10 pages By-Laws of Biocryst Pharmaceuticals, Inc. Updated 8/6/01
12/34/56